Clinical Trials
3 trialsNCT02590965 2020-02-13
A Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung Cancer
Hutchmed
Phase 2 Completed
NCT03684967 2019-11-19
Study of Fruquintinib (HMPL-013) in High Risk Patients With Advanced NSCLC
Hutchmed
Phase 2 Withdrawn
NCT02976116 2019-11-15
A Phase II Study of Fruquintinib in Combination With Gefitinib in Patients With Advanced Non-small Cell Lung Cancer
Hutchmed
Phase 2 Completed